Mirtazapine Torrent Pharma (Uk)

Mirtazapine, the active ingredient in Mirtazapine Torrent Pharma, is a tetracyclic antidepressant presented as an oral tablet for oral use. It is prescribed for the treatment of major depressive disorder in adult patients, helping to improve mood, sleep and appetite. GNH USA supplies Mirtazapine Torrent Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mirtazapine is a tetracyclic antidepressant used to manage depressive disorders. - Major depressive disorder: reduces depressive symptoms and improves overall mood in adults. - Depression with insomnia: promotes sleep onset and improves sleep quality alongside mood benefits. - Depression with anxiety: alleviates anxiety symptoms that often accompany depressive episodes.

Mirtazapine may cause a range of adverse reactions.

Common Side Effects: - Sedation or drowsiness - Increased appetite and weight gain - Dry mouth - Dizziness

Serious or Rare Side Effects: - Agranulocytosis or severe neutropenia - Hepatotoxicity - Seizures - Hyponatremia - Suicidal thoughts or behavior

When prescribing mirtazapine, clinicians should consider several safety measures. - Hepatic function: assess liver status before initiation and during therapy. - Weight monitoring: track body weight and appetite changes regularly. - Elderly patients: use caution due to increased risk of sedation and falls. - Discontinuation: avoid abrupt cessation to reduce withdrawal symptoms. - Suicidal ideation: monitor for emergence or worsening of suicidal thoughts, especially early in treatment. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Mirtazapine can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - CNS depressants (e.g., benzodiazepines, opioids): additive sedation. - Alcohol: enhances central nervous system depression.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): potential serotonin syndrome. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increased bleeding risk. - Antihypertensives: possible additive hypotensive effect.